Abstract
Objective To study the correlation between interleukin (IL)-21 and the recurrence of chronic hepatitis B (CHB) in hepatitis B e antigen (HBeAg)-positive patients after discontinuation of entecavir (ETV). Methods A total of 112 HBeAg-positive CHB patients treated with ETV were enrolled. Serum levels of IL-21 at week 0, 12, 24 and 52 after ETV discontinuation were detected. The Cox regression model was used to analyze the correlation between IL-21 and the recurrence after ETV discontinuation. The receiver operating characteristic (ROC) curve was applied to determine the predictive value of IL-21 for CHB recurrence after ETV discontinuation. The expression differences of IL-21 were compared between sustained viral response (SVR) group and viral relapse (VR) group. The t test and Chi-square test were used for statistical analysis. Results The serum levels of IL-21 in SVR group at week 0, 12, 24 and 52 after ETV withdrawal were (60.0±10.8), (60.2±14.7), (60.6±19.5) and (61.2±15.4) ng/L, respectively, which were all significantly higher than those in VR group (47.5±10.7), (47.3±12.9), (46.9±12.2) and (46.4±12.8) ng/L, respectively (t=6.153, 4.926, 4.382 and 5.515, respectively, all P<0.01). The area under curve (AUC) was 0.811 (95%CI: 0.728~0.893, P<0.01) and the best cut-off value of serum IL-21 level was 49.8 ng/L. The recurrence rates of patients with serum IL-21 level ≥49.8 ng/L and <49.8 ng/L at time of ETV withdrawal was 25.4% (16/63) and 77.6% (38/49), respectively. The difference was statistically significant (χ2=30.027, P<0.01). The serum IL-21 level at the time of drug withdrawal (P=0.005), serum hepatitis B surface antigen (HBsAg) level at the time of HBeAg seroconversion (P=0.008) and age (P=0.016) were factors associated with CHB recurrence after ETV withdrawal by multivariate Cox model analysis. The serum levels of ALT, HBV DNA, HBeAg and HBsAg in SVR group were significantly lower than those of VR group at week 12, 24 and 52 after ETV withdrawal (t=-5.968, -7.691, -8.093; -3.047, -9.477, -28.900; -2.872, -10.424, -18.330; -4.633, -4.030 and -5.032, respectively; all P<0.01). Serum level of IL-21 was negatively correlated with HBsAg in SVR group after ETV withdrawal (r=-0.241, P<0.01), while positively correlated with HBsAg in VR group (r=0.286, P<0.01). Conclusions The serum IL-21 level at the time of drug withdrawal is associated with the recurrence after ETV discontinuation. IL-2l may play an important role as an immunomodulatory factor in maintaining virological responses in HBeAg-positive CHB patients after ETV withdrawal. Key words: Cytokines; Hepatitis B, chronic; Recurrence; Entecavir; Withdrawal
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.